ZA903588B - Excitatory amino acid antagonists - Google Patents

Excitatory amino acid antagonists

Info

Publication number
ZA903588B
ZA903588B ZA903588A ZA903588A ZA903588B ZA 903588 B ZA903588 B ZA 903588B ZA 903588 A ZA903588 A ZA 903588A ZA 903588 A ZA903588 A ZA 903588A ZA 903588 B ZA903588 B ZA 903588B
Authority
ZA
South Africa
Prior art keywords
amino acid
excitatory amino
acid antagonists
antagonists
excitatory
Prior art date
Application number
ZA903588A
Other languages
English (en)
Inventor
Boyd Lynn Harrison
Lynn Harrison Boyd
Bruce Michael Baron
Michael Baron Bruce
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of ZA903588B publication Critical patent/ZA903588B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Quinoline Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
ZA903588A 1989-05-16 1990-05-10 Excitatory amino acid antagonists ZA903588B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35242389A 1989-05-16 1989-05-16

Publications (1)

Publication Number Publication Date
ZA903588B true ZA903588B (en) 1991-02-27

Family

ID=23385074

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA903588A ZA903588B (en) 1989-05-16 1990-05-10 Excitatory amino acid antagonists

Country Status (19)

Country Link
EP (1) EP0398283B1 (el)
JP (1) JP3014001B2 (el)
KR (1) KR0169107B1 (el)
CN (1) CN1027369C (el)
AT (1) ATE113597T1 (el)
AU (1) AU626418B2 (el)
DE (1) DE69013750T2 (el)
DK (1) DK0398283T3 (el)
ES (1) ES2066035T3 (el)
FI (1) FI95795C (el)
GR (1) GR3014893T3 (el)
HU (1) HU214322B (el)
IE (1) IE64671B1 (el)
IL (1) IL94377A (el)
NO (1) NO177141C (el)
NZ (1) NZ233641A (el)
PT (1) PT94042B (el)
TW (1) TW207950B (el)
ZA (1) ZA903588B (el)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028707A (en) * 1989-11-20 1991-07-02 Board Of Regents, University Of Texas 4-hydroxyquinaldic acid derivatives
DK101290D0 (da) * 1990-04-24 1990-04-24 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
US5606063A (en) * 1991-02-27 1997-02-25 Merrell Pharmaceuticals Inc. NMDA antagonists
EP0573562B1 (en) * 1991-02-27 1996-04-24 Merrell Pharmaceuticals Inc. Dihydroquinoline NMDA antagonists
GB9200781D0 (en) * 1992-01-15 1992-03-11 Merck Sharp & Dohme Therapeutic agents
US5464843A (en) * 1992-06-23 1995-11-07 G.D. Searle & Co. Imidazo[1,2-a]pyridinyldiacid compounds for cognitive enhancement and for treatment of cognitive disorders and neutrotoxic injury
FR2722786B1 (fr) * 1994-07-20 1996-08-23 Rhone Poulenc Rorer Sa Derives de 4-hydroxy-3-phenyl-indeno(1,2-b)pyridine-2(1h)- one, leur preparation et les medicaments les contenant
DE4444815A1 (de) * 1994-12-15 1996-06-20 Merck Patent Gmbh Thienopyridone
AU5533996A (en) * 1996-04-04 1997-10-29 University Of Nebraska Board Of Regents Synthetic triple helix-forming compounds
JP4234344B2 (ja) * 1999-12-28 2009-03-04 エーザイ・アール・アンド・ディー・マネジメント株式会社 スルホンアミド含有複素環化合物
JP2004527508A (ja) * 2001-03-14 2004-09-09 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 鎮痛剤としての置換されたピラゾロ−及びチアゾロピリミジン類
FR2864535B1 (fr) * 2003-12-24 2006-12-22 Merck Sante Sas Derives acides de quinoline et leurs applications en therapeutique
GB0420719D0 (en) * 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
AU2009235784B2 (en) 2008-04-11 2013-09-19 Merck Patent Gmbh Thienopyridone derivatives as AMP-activated protein kinase (AMPK) activators
DE102008019838A1 (de) * 2008-04-19 2009-12-10 Boehringer Ingelheim International Gmbh Neue Arylsulfonylglycin-Derivate, deren Herstellung und deren Verwendung als Arzneimittel
WO2017121308A1 (en) * 2016-01-11 2017-07-20 Chongqing Fochon Pharmaceutical Co., Ltd. Fused pyridine compounds, compositions and methods of use
WO2018202039A1 (zh) * 2017-05-03 2018-11-08 成都海创药业有限公司 杂环化合物及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2563831B1 (fr) * 1984-05-04 1986-11-21 Sanofi Sa Nouveaux derives de thienopyridinone, leur procede de preparation et compositions pharmaceutiques les contenant
GB8627698D0 (en) * 1986-11-20 1986-12-17 Boots Co Plc Therapeutic agents
GB8804448D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
EP0403885A1 (de) * 1989-06-20 1990-12-27 Bayer Ag Verwendung von 3-Hydroxybenzothiophenen zur Bekämpfung von Endoparasiten, neue 3-Hydroxybenzothiophene und Verfahren zu ihrer Herstellung
EP0446604A3 (en) * 1990-03-16 1992-02-19 American Cyanamid Company Pyridine and related aza heterocycle derivatives as cardiovascular agents

Also Published As

Publication number Publication date
PT94042B (pt) 1997-05-28
DE69013750T2 (de) 1995-05-24
DE69013750D1 (de) 1994-12-08
AU626418B2 (en) 1992-07-30
NO177141B (no) 1995-04-18
NZ233641A (en) 1992-07-28
IL94377A0 (en) 1991-03-10
GR3014893T3 (en) 1995-05-31
JP3014001B2 (ja) 2000-02-28
TW207950B (el) 1993-06-21
KR900018112A (ko) 1990-12-20
HU214322B (hu) 1998-03-02
CN1027369C (zh) 1995-01-11
EP0398283A1 (en) 1990-11-22
ATE113597T1 (de) 1994-11-15
PT94042A (pt) 1991-01-08
HUT54657A (en) 1991-03-28
FI902416A0 (fi) 1990-05-15
FI95795B (fi) 1995-12-15
NO902179D0 (no) 1990-05-15
HU903031D0 (en) 1990-09-28
EP0398283B1 (en) 1994-11-02
AU5491490A (en) 1990-11-22
CN1047292A (zh) 1990-11-28
KR0169107B1 (ko) 1999-01-15
IL94377A (en) 1997-01-10
FI95795C (fi) 1996-03-25
JPH0311067A (ja) 1991-01-18
NO902179L (no) 1990-11-19
NO177141C (no) 1995-07-26
DK0398283T3 (da) 1994-11-28
ES2066035T3 (es) 1995-03-01
IE64671B1 (en) 1995-08-23
IE901750L (en) 1990-11-16

Similar Documents

Publication Publication Date Title
TW207950B (el)
MX9203338A (es) Nuevos derivados del oxico a_nor-esteroide-3-carboxilico.
ZA908156B (en) Fibrinogen receptor antagonists
DE69033308D1 (de) Decahydro-isochinolin-derivate
GR3017792T3 (en) Excitatory amino acid antagonists.
GR3019689T3 (en) Excitatory amino acid antagonists
ATE179169T1 (de) Prostaglandinanaloge
FI875295A (fi) Menetelmä hirudiinivariantin valmistamiseksi
DE69230224D1 (de) Potenzierung von nmda-antagonisten
IT1215973B (it) Analoghi della ammino prostaglandina 7 ossabicicloeptansostituiti.
PT90504A (pt) Processo para a preparacao de alcoois peptidicos com actividade anticoagulante
ATE130009T1 (de) Antitumor-aminosäuren und peptid-derivate von 1,4-bis((aminoalkyl und hydroxyaminoalkyl)amino>5,8- dihydroxyanthraquinonen.
GR3019047T3 (en) Heterocyclic-NMDA antagonists.
DE3887426T2 (de) Eperisone als Hypotonikum.
ATE110385T1 (de) Derivate von aminocarboxylsäure.
IT8607001A0 (it) Atomizzatore d'alicandro
KR900700012A (ko) 엽면 살포제
IT8719949A0 (it) Composizioni farmaceutiche adattivita' immunomodulante.
IT8720701A0 (it) Composizioni farmaceutiche adattivita' immunomodulante.